Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 151 AL 165

Developing Disease-Modifying Treatments in Alzheimer's Disease - A Perspective from Roche and Genentech

Doody R.

J Prev Alzheimers Dis. 2017;4(4):264-272. doi: 10.14283/jpad.2017.40.

Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential

Abushakra S, Porsteinsson A, Scheltens P, Sadowsky C, Vellas B, Cummings J, Gauthier S, Hey JA, Power A, Wang P, Shen L, Tolar M.

J Prev Alzheimers Dis. 2017;4(3):149-156. doi: 10.14283/jpad.2017.26.

Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study

Kahle-Wrobleski K, Andrews JS, Belger M, Ye W, Gauthier S, Rentz DM, Galasko D.

J Prev Alzheimers Dis. 2017;4(2):72-80. doi: 10.14283/jpad.2017.2.

EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials

Aisen P, Touchon J, Amariglio R, Andrieu S, Bateman R, Breitner J, Donohue M, Dunn B, Doody R, Fox N, Gauthier S, Grundman M, Hendrix S, Ho C, Isaac M, Raman R, Rosenberg P, Schindler R, Schneider L, Sperling R, Tariot P, Welsh-Bohmer K, Weiner M, Vellas B.

J Prev Alzheimers Dis. 2017;4(2):116-124. doi: 10.14283/jpad.2017.13.

Autobiographical memory compromise in Alzheimer's disease: a cognitive and clinical overview

El Haj M, Roche J, Gallouj K, Gandolphe MC.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Dec 1;15(4):443-451. doi: 10.1684/pnv.2017.0704.

Association of Cortical β-Amyloid with Erythrocyte Membrane Monounsaturated and Saturated Fatty Acids in Older Adults at Risk of Dementia

Hooper C, De Souto Barreto P, Payoux P, Salabert AS, Guyonnet S, Andrieu S, Sourdet S, Delrieu J, Vellas B.

J Nutr Health Aging. 2017;21(10):1170-1175. doi: 10.1007/s12603-017-0975-3.

Study partners should be required in preclinical Alzheimer's disease trials

Grill JD, Karlawish J.

Alzheimers Res Ther. 2017 Dec 6;9(1):93. doi: 10.1186/s13195-017-0327-x.

Can the retina be used to diagnose and plot the progression of Alzheimer's disease?

Mahajan D, Votruba M.

Acta Ophthalmol. 2017 Dec;95(8):768-777. doi: 10.1111/aos.13472. Epub 2017 Jun 9.

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P; SCarlet RoAD Investigators.

Alzheimers Res Ther. 2017 Dec 8;9(1):95. doi: 10.1186/s13195-017-0318-y.

Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment

Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A.

Sci Rep. 2017 Dec 13;7(1):17490. doi: 10.1038/s41598-017-17718-y.

[Music therapy as a non-pharmacological treatment in Alzheimer's disease. A systematic review]

Garcia-Casares N, Moreno-Leiva RM, Garcia-Arnes JA.

Rev Neurol. 2017 Dec 16;65(12):529-538.

Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease

Wu XL, Piña-Crespo J, Zhang YW, Chen XC, Xu HX.

Chin Med J (Engl). 2017 Dec 20;130(24):2978-2990. doi: 10.4103/0366-6999.220313.

Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial

Jia Y, Zhang X, Yu J, Han J, Yu T, Shi J, Zhao L, Nie K.

BMC Complement Altern Med. 2017 Dec 29;17(1):556. doi: 10.1186/s12906-017-2064-x.

The clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial

Li M, Lyu JH, Zhang Y, Gao ML, Li WJ, Ma X.

Medicine (Baltimore). 2017 Dec;96(51):e9381. doi: 10.1097/MD.0000000000009381.

A Brief Review of Caprylidene (Axona) and Coconut Oil as Alternative Fuels in the Fight Against Alzheimer's Disease

Chintapenta M, Spence J, Kwon HI, Blaszczyk AT.

Consult Pharm. 2017 Dec 1;32(12):748-751. doi: 10.4140/TCP.n.2017.748.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias